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Carbonmonoxide(CO)mayexertimportantrolesinphysiologicalandpathophysiologicalstatesthroughtheregulationofcellular
signaling pathways. CO can protect organ tissues from ischemia/reperfusion (I/R) injury by modulating intracellular redox status
andbyinhibitinginflammatory,apoptotic,andproliferativeresponses.However,thecellularmechanismsunderlyingtheprotective
effects of CO in organ I/R injury remain incompletely understood. In this study, a murine model of hepatic warm I/R injury was
employed to assess the role of glycogen synthase kinase-3 (GSK3) and phosphatidylinositol 3-kinase (PI3K)-dependent signaling
pathwaysintheprotectiveeffectsofCOagainstinflammationandinjury.InhibitionofGSK3throughthePI3K/Aktpathwayplayed
a crucial role in CO-mediated protection. CO treatment increased the phosphorylation of Akt and GSK3-beta (GSK3𝗽) in the liver
after I/R injury. Furthermore, administration of LY294002, an inhibitor of PI3K, compromised the protective effect of CO and
decreased the level of phospho-GSK3𝗽 after I/R injury. These results suggest that CO protects against liver damage by maintaining
GSK3𝗽 phosphorylation, which may be mediated by the PI3K/Akt signaling pathway. Our study provides additional support for
the therapeutic potential of CO in organ injury and identifies GSK3𝗽 as a therapeutic target for CO in the amelioration of hepatic
injury.
1. Introduction
Hepatic ischemia/reperfusion (I/R) injury is a cause of sig-
nificant morbidity and mortality after liver transplantation,
hemorrhagic shock, and extended liver resection for cancer.
The pathophysiology of liver I/R injury includes both initial
c e l l u l a rd a m a g ed u et oi s c h e m i aa sw e l la sd e l a y e dl i v e rd y s -
function following reperfusion-initiated and inflammation-
induced hepatocellular damage [1]. During I/R injury, Toll-
like receptor 4 (TLR4) activation leads to neutrophil infil-
tration and may promote liver damage through the increase
of proinflammatory cytokines. I/R injury can cause chronic
inflammation and disease through TLR4 activation [2].
TLR4 activation by lipopolysaccharide (LPS) can be sup-
pressed by the cytoprotective heme oxygenase-1/carbon
monoxide (HO-1/CO) system [3]. CO, a reaction product of
HO-1activity,hasbeen shownto havepotentanti-inflamma-
tory, antiproliferative, and antiapoptotic effects and thereby
mimics the cytoprotective effects of HO-1 [4]. CO, when
applied at low concentration, can confer anti-inflammatory
effects in macrophages and protect endothelial cells and hep-
atocytes against cytotoxic agents [5, 6]. Likewise, the exoge-
nous application of gaseous CO also protects against cold
hepaticI/Rinjuryintheexvivoisolatedliverperfusionmodel
[7]. Although CO inhalation or pharmacological application
using CO-releasing molecules (CORMs) has been reported2 Oxidative Medicine and Cellular Longevity
to ameliorate I/R injury in various animal models [7–9], the
molecular mechanisms underlying the cytoprotective effects
of the HO-1/CO system on hepatic I/R injury have not been
well studied.
Recent studies have shown that inhibition of glycogen
synthase kinase 3𝗽 (GSK3𝗽) by Ser9 phosphorylation can
confer cardioprotective effects during myocardial infarction
[10, 11], and ameliorate liver I/R injury [12]. GSK3𝗽 activity
has recently been identified in a number of studies as cru-
cial in the regulation of the inflammatory response. Phos-
phatidylinositol-3-kinase (PI3K)/Akt-dependent inhibition
of GSK3𝗽activityinmonocytescan regulateTLR-dependent
activation [13, 14]. Although hepatic I/R injury has been
reported to be ameliorated by inhibition of GSK3𝗽,t h em o l -
ecular mechanisms by which GSK3𝗽 confers cytoprotective
effects in hepatic I/R injury through TRL4 modulation have
not been well studied.
In this study, we establish a signaling pathway by which
COzcanconferanti-inflammatoryprotectionforliverhome-
ostasis. We demonstrate that CO inhibits GSK3𝗽 activity
throughaPI3K/Akt-mediatedpathway,leadingtothedown-
regulation of TLR4-dependent proinflammatory cytokines,
andtheupregulationofIL-10.Ourresultsfurthervalidatethe
use of CO as a pharmacological cytoprotective agent against
hepatic I/R injury and identify GSK3𝗽 as a major therapeutic
target of CO action in the liver.
2. Materials and Methods
2.1. Animal. Male C57BL/6 wild type (WT) mice at 8–10
weeks of age were purchased from the Orient Bio (Seoul,
Korea). Animals were maintained in a specific pathogen-free
facility. Animal studies were approved by the University of
U l s a nA n i m a lC a r ea n dU s eC o m m i t t e e .
2.2. Cell Culture. The human hepatocarcinoma cell line
(HepG2) and the murine macrophage cell line, RAW 264.7,
were cultured in DMEM (Gibco, Grand Island, NY). All
media was supplemented with 10% fetal bovine serum and a
100units/mL penicillin-streptomycin mixture (Gibco).
2.3. Carbon Monoxide Treatment. To evaluate the protective
effect of inhaled CO, animals were randomly assigned to
receive preconditioning with room air or room air supple-
mentedwith250partspermillion(ppm)CO ,for12hoursina
sealed exposure chamber prior to the experiment. Mice were
exposed to CO 250ppm for 1hour and 6hours after reperfu-
sion.
2.4.MouseLiverI/RInjuryModel. Weusedawell-established
mouse model of warm hepatic ischemia followed by reperfu-
sion [15]. An atraumatic clip was used to interrupt the arte-
rial/portal venous blood supply to the cephalad liver lobes.
After90minutestheclipwasremoved;miceweresacrificedat
various time points of reperfusion. Sham wild-type (WT)
controlsunderwentthesameprocedure,butwithoutvascular
occlusion. Mice were exposed to compressed air or carbon
monoxide (CO), at 250parts per million (ppm). CO or room
a i rw a sg i v e nt ot h em o u s eo v e r n i g h tp r i o rt ot h el i v e ri s c h e -
mia and during reperfusion. In some experiments, the PI3K
inhibitor LY294002 (Sigma, St Louis, MO, 0.5mg/kg, i.p.)o r
vehicle(10%D MSOinPBSi.p.)wasgiven30minpriortothe
ischemic insult.
2.5. Hepatocellular Damage Assay. To detect serum alanine
aminotransferase (sALT), serum was collected from periph-
eralblood.ALTactivity,anindicatorofhepatocellularinjury,
was measured using the EnzyChrom Alanine Transaminase
Assay Kit (BioAssay System, Hayward, CA).
2.6. Liver Histology. For histopathological observations, por-
tions of liver were fixed in 10% neutral-buffered formalin
solutionandthendehydratedingradedalcohol.Thefixedtis-
sue was embedded in paraffin and sliced into 4𝜇mt h i c ks e c -
tions. Tissue sections were mounted on regular glass slides,
deparaffinized in xylene, rehydrated in decreasing concen-
trations of ethanol, and stained with hematoxylin and eosin
(H&E). Overall pathological changes, including immune cell
infiltration and hepatic cell necrosis, were diagnosed accord-
ing to previously described methods [16].
2.7. Immunohistochemistry. For the detection of p-GS (S641)
and p-GSK3𝗽 (S9) by immunohistochemistry, the tyramide
signal amplification (TSA) biotin system (Perkin-Elmer,
Waltham, MA) was used according to the protocols recom-
mended by the manufacturer. Briefly, after blocking, the sec-
tionswereincubatedfirstwitheitheranti-p-GS(S641)oranti-
p-GSK3𝗽 (S9) antibody (Cell Signaling Technologies, Dan-
vers, MA). After overnight incubation, the sections were
washed and then incubated with biotinylated anti-rabbit IgG
antibody, next with streptavidin-horseradish peroxidase
(HRP),andthenwiththebiotinyltyramideamplificationrea-
gent.Depositionofthebiotin-tyramideontissuesectionswas
visualized with streptavidin-HRP and the substrate diami-
nobenzidine (DAB; Merck, Darmstadt, Germany); and then
the sections were then counterstained with hematoxylin.
2.8. Immunoprecipitation. Preparation of nuclear extracts
was carried out using the Nuclear/Cytosol Fractionation Kit
(BioVision, Milpitas, CA). Proteins in the cell lysates were
immunoprecipitated with anti-CBP antibodies for 3h at 4
∘C,
followed by incubation with Dynabeads protein G overnight
at 4
∘C. Proteins in the immunoprecipitates were resolved
using SDS-PAGE, followed by Western blotting with anti-
phospho-NF-𝜅B p65 and anti-phospho-CREB antibodies
(Santa Cruz Biotechnology, Santa Cruz, CA).
2.9. SDS-PAGE Analysis and Immunoblotting. Harvested
liver tissues and cells were lysed with mammalian lysis
buffer containing phosphatase and protease inhibitors. Equal
amounts of cell lysates were measured with the BCA protein
assay reagent (Pierce Biotechnology, Rockford, IL). Lysates
were boiled in sample buffer containing 𝗽-mercaptoethanol
for 5min. Proteins were then subjected to SDS-PAGE and
transferred to polyvinylidene difluoride membranes (GE
healthcare,Piscataway,NJ).Afterblockingwith5%skimmilkOxidative Medicine and Cellular Longevity 3
in PBS, membranes were incubated with appropriate dilu-
tions of antibodies at 4
∘C overnight as follows: polyclonal
rabbit anti-phospho glycogen synthase kinase (Ser9), rabbit
anti-phospho glycogen synthase (Ser641), mouse anti-gly-
cogen synthase kinase, rabbit anti-glycogen synthase, rabbit
anti-phospho CREB (Ser133), rabbit anti-phospho Akt
(Ser473), rabbit anti-HMGB1 (Cell Signaling Technology,
Danvers, MA), rabbit anti-CBP, rabbit anti-phospho-NF-𝜅B-
p65 (Ser276), and 𝗽-actin (Santa Cruz Biotechnology, Santa
Cruz, CA) were used. Membranes were then washed with
0.05% PBS-Tween 20 and incubated with a 1/5000 dilution of
HRP-conjugated secondary Abs at room temperature for 1h.
Immunoreactivity was detected using the ECL detection sys-
tem (GE Healthcare, Piscataway, NJ). Films were exposed at
multiple time points to ensure that the images were not
saturated.
2.10. Real-Time and Semiquantitative RT-PCR. Total RNA
waspreparedusingTrizolreagent(Invitrogen,Carlsbad,CA).
Three microgram of total RNA was used to synthesize the
first-strandcDNAbyusingoligo-dTprimers(QIAGEN,CA)
and M-MLV reverse transcriptase (Promega, Madison, WI)
accordingtothemanufacturer’sinstructions.Thesynthesized
cDNA was subjected to the PCR-based amplification. Semi-
quantitative RT-PCR was performed using Taq polymerase
(Solgent, Daejeon, Korea). Real-time PCR was performed
using SYBR Green PCR Master Mix (Qiagen, Valencia, CA)
onanABI7500FastReal-TimePCRSystem(AppliedBiosys-
tems, Grand Island NY). PCR primer pairs were as follows:
TNF: 5
򸀠- A G ACCCT C AC A CT C AG A TC A TC TTC - 3
򸀠,5
򸀠-
TTG CTA CGA CGT GGG CTA CA-3
򸀠,I L - 6 :5
򸀠-CGA TGA
TGC ACT TGC AGA AA-3
򸀠,5
򸀠-TGG AAA TTG GGG TAG
GAA GG-3
򸀠 and IL-10: 5
򸀠-CAG TAC AGC CGG GAA GAC
AA-3
򸀠,5
򸀠-CAG CTT CTC ACC CAG GGA AT-3
򸀠.
2.11. Myeloperoxidase Assay. Neutrophil sequestration in
liverwasquantifiedbymeasuringtissueMPOactivity.Tissue
s a m p l e sf o rM P Oa n a l y s i sw e r ef r o z e ni nl i q u i dn i t r o g e n
immediately after removal from the animal and were thawed
and homogenized and centrifuged to remove insoluble mat-
erials. MPO activities were measured using a mouse mye-
loperoxidase DuoSet ELISA kit (R&D Systems, Minneapolis,
MN) according to the manufacturer’s instruction. The super-
natants were analyzed for MPO levels by sandwich ELISA.
The levels of MPO in organ extracts were expressed as ng/mg
of protein.
2.12. Statistical Analysis. All data were expressed as mean ±
SD.Differencesbetweenexperimentalgroupswerecompared
using the Student’s two-tailed unpaired t-test.
3. Results
3.1. Carbon Monoxide Inhalation Protects Liver Ischemia/Re-
perfusionInjuryviaAKT-GSK3𝗽ActivationinMice. Carbon
monoxide (CO) has been shown to exert protective effects in
various tissue models of I/R injury [8, 9, 17]. We analyzed
the effect of CO on hepatocellular function in mouse livers
subjected to 90min of warm ischemia followed by 6h
reperfusion.AsshowninFigure1(a),sALTlevelsinmicesub-
jected to hepatic I/R were decreased in animals pretreated
withCOgas,ascomparedwithroomair(3225±891U/L ver-
sus1091 ± 230U/L, respectively, 𝑃 < 0.01). Figure 1(b) shows
that hepatocellular necrosis (panels (A)–(C)) and immune
cellinfiltration(panel(D)–(F))observedintheair-treatedI/R
group were markedly reduced with CO inhalation. Further-
more, myeloperoxidase (MPO) activity, reflecting liver neu-
trophil activity, was decreased in the CO inhalation group,
comparedwiththeair-treatedgroupafterhepaticI/R(5.371±
0.902ng/mg versus 10.468 ± 1.700ng/mg, resp., 𝑃 < 0.01)
(Figure 1(c)). Since HMGB1, an inflammatory cytokine, can
promote liver damage following I/R injury [18, 19], we exam-
ined HMGB1 expression in our hepatic I/R model. As shown
in Figure 1(d), I/R caused an increase in hepatic HMGB1
expression when compared with sham control mice. CO
inhalation markedly attenuated the expression of HMGB1
during I/R injury compared to air-treated mice subjected to
I/R (Figure 1(d)).
Previous reports have shown that HO-1 derived CO
can activate the PI3K-Akt pathway [20]a n dt h e r e b yc o n f e r
protection against cardiac I/R injury [21]. To investigate
whether CO activates Akt signaling in hepatic cell lines, we
assessed the expression of phosphorylated (p)-Akt and of
GSK3𝗽, which is negatively regulated by Akt. As shown in
Figure 1(e), CO increased the phosphorylation of both Akt
and GSK3𝗽 in HepG2 cells. Conversely, CO decreased the
phosphorylation of GS, the substrate of GSK3𝗽.
A previous study has shown that both endogenous and
exogenous CO can increase cellular ROS generation [22].
ROS can exert a critical role in maintaining homeostasis by
protecting the host against excessive inflammatory responses
[23]. Because activation of the phosphatidylinositol 3-kinase
(PI3K)/Akt pathway by ROS signaling can function in cel-
lular adaptation [24, 25], we sought to determine whether
CO-mediated ROS generation can increase LPS-induced
phosphorylation of Akt and GSK3. As shown in Figure 1(f),
weusedtheROSscavengerN-acetyl-cysteine(NAC)todeter-
minewhetherphosphorylationofAktandGSK3𝗽wasmodu-
lated by ROS generation. Treatment with CO dramatically
increased LPS-induced phosphorylation of Akt and GSK3𝗽.
Inhibition of ROS generation with NAC attenuated LPS/CO-
induced phosphorylation of Akt and GSK3𝗽. These results
suggest that CO stimulates LPS-dependent PI3K/Akt-
GSK3𝗽 phosphorylation via enhanced ROS production.
Therefore, to examine whether CO activates PI3K/Akt
signaling during hepatic I/R injury, we examined the expres-
sionofp- AktinmicesubjectedtohepaticI/R.Therewasasig-
nificantincreaseinp- AktintheCO-treatedmicesubjectedto
hepatic I/R injury at 1hour of reperfusion relative to air-
treated controls, which was sustained until 6hours of reper-
fusion (Figure 1(g)). These findings suggested that the Akt-
GSK3𝗽 a x i sm a yb ei n v o l v e di nC O - m e d i a t e dp r o t e c t i o ni n
the liver I/R model.
3.2. The Protective Effect of CO in Liver Ischemia/Reperfusion
Injury Is Dependent on the Inactivation of GSK3 Activity. I/R
stimulation has been previously shown to trigger GSK3𝗽4 Oxidative Medicine and Cellular Longevity
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Figure 1: Pretreatment of mice with CO gas inhalation ameliorates liver I/R injury via AKT-GSK3𝗽 activation. Mice were subjected to
90minutes liver warm ischemia, followed by 6h reperfusion. (a) Hepatocellular function was evaluated by sALT (IU/L). (b) Representative
liver histology of ischemic liver lobes. (c) Liver neutrophil accumulation, assessed by MPO activity. Data represent the mean ± standard
deviation (SD) (𝑁 = 4–6samples/group).
∗∗𝑃 < 0.01. (d) Hepatic HMGB1 expression in liver tissue was assessed by Western blot analysis
at 1h and 6h of reperfusion. Total cell lysates were analyzed for HMGB1 and 𝗽-actin protein levels by Western blot analysis. (e) Western-
blot analysis of phospho (p)-GSK3𝗽 (Ser 9), p-GS (Ser641), and p-Akt in HepG2 cells after treatment with CORM2 (50𝜇M) at the indicated
times.(f)RAW264.7cellswerestimulatedwith10ng/mLofLPSfor30minutesintheabsenceorpresenceofCORM2andtheROSscavenger,
N-acetyl-cysteine (NAC). Total cell lysates were analyzed for phosphorylated GS, GSK3𝗽,a n dA k ta sw e l la st o t a lG S ,G S K 3 𝗽,A k t ,a n d𝗽-
actin protein levels by Western immunoblot analysis. (g) Mice were subjected to 90minutes of liver warm ischemia, followed by 1h or 6h
reperfusion. Liver tissue was analyzed by Western blotting of p-Akt and total Akt. 𝗽-Actin served as the standard.Oxidative Medicine and Cellular Longevity 5
phosphorylation in mouse liver as a self-regulatory mech-
anism [12]. Given that inhibition of GSK3𝗽 is involved in
amelioration of liver pathology, we hypothesized that GSK3𝗽
inhibition may represent the underlying mechanism for CO-
mediated liver protection. To evaluate the potential role of
GSK3𝗽 in CO-mediated liver protection, we analyzed the
effects of CO on GSK3𝗽 phosphorylation at Ser-9 and glyco-
gen synthase (GS) phosphorylation at Ser-641, the substrate
of GSK3𝗽.A ss h o w ni nF i g u r e2(a), mice exposed to CO
inhalation displayed marked increases in the phosphoryla-
tionofGSK3𝗽intheischemiclivers,comparedwiththesham
control and air-inhaled groups. Conversely, the level of GS
phosphorylation was decreased in ischemic mice given CO
inhalation, compared with the air inhalation group. Accord-
ing to a previous report (26), the decrease of GS phosphoryl-
ation that occurs in response to I/R stimulation alone is due
toGSphosphataseactivationbyI/R.Thus,transientischemia
induces GS activation and glycogen synthesis in vivo.Th e s e
observations suggest that this occurs through a different
m e c h a n i s mt h a nt h r o u g ht h ei n c r e a s eo fp G S K 3 - 𝗽,a s
observed with CO treatment.
Previous studies have demonstrated that the cytopro-
tective effects of CO involve p38 MAPK signaling [7].
Consistently, we found that phosphorylated p38 MAPK was
increased by CO inhalation in the livers of mice subjected
to hepatic I/R, compared with air-treated control mice
(Figure 2(a)).However,JNKphosphorylationwasnotaltered
by CO.
We used immunohistochemistry to examine whether
CO-mediated liver protection was associated with GSK3
inhibition. As shown in Figure 2(b),i n h a l a t i o nw i t hC Og a s
increased GSK3𝗽 phosphorylation in ischemic liver and re-
duced GS phosphorylation, as compared with the air-inhal-
ation group. Consistent with immunohistochemistry data,
decreased mRNA levels of TNF-𝗼,I L - 6 ,a n dC X C L 1 0w e r e
consistently found in the livers of mice subjected to CO-
inhalation, compared with those of the air-inhalation group
(Figure 2(c)). TNF-𝗼 and IL-6 proteins production was also
inhibited by CO (Figure 2(d)). The anti-inflammatory cyto-
kine IL-10 was significantly increased by CO inhalation in
mice subjected to hepatic I/R injury (Figures 2(c) and 2(d)).
3.3. CO Dependent Inhibition of GSK3 and Attenuation of
Liver Injury Involve PI3K Signaling in Mice. The PI3K-Akt
pathway has been shown in vitro to regulate GSK3𝗽 phos-
phorylation through the activation of TLR4 [26]. We used
LY294002, an irreversible PI3K-specific inhibitor, to address
the functional role of PI3K/Akt signaling in CO-mediated
liver cytoprotection. Indeed, LY294002-treated mice dis-
played significantly lower levels of phosphorylated GSK3𝗽 in
the liver after I/R (Figure 3(a)). Increased sALT levels were
c o n s i s t e n t l yf o u n di nm i c et r e a t e dw i t ht h eP I 3Ki n h i b i t o r
with or without CO inhalation (Figure 3(b), 11791 ± 940U/L
and 9012 ± 3657U/L, resp.), compared with CO inhalation
alone (2423 ± 1145U/L, 𝑃 < 0.01)( F i g u r e3(b)). Unlike mice
pretreated with CO, which displayed minimal liver damage
(Figure 3(c), panel (D)), mice given the PI3K inhibitor
revealed significant hepatocellular necrosis, cytoplasmic vac-
uolization, and sinusoidal congestion (panel (C)). Livers of
animals treated with the PI3K inhibitor after CO inhalation
showed moderate to severe hepatocellular changes (panel
(E)). As shown in Figure 3(d),M P Ol e v e l sw e r ee l e v a t e di n
PI3K inhibitor-treated mice (12.458 ± 1.947ng/mg), com-
pared with DMSO controls (7.864 ± 0.891ng/mg, 𝑃 < 0.01).
In contrast, livers from the CO inhalation group showed de-
creased MPO activity (3.738 ± 1.203ng/mg), compared with
the group subjected to PI3K inhibitor treatment after CO
inhalation (9.964 ± 3.099, 𝑃 < 0.01). Thus, PI3K/Akt-
dependent GSK3𝗽 phosphorylation, a therapeutic target of
CO, serves as a self-regulatory mechanism of liver homeosta-
sis to limit the excessive I/R-induced tissue damage.
3.4. CO-Mediated GSK3 Inhibition via PI3K/AKT Signaling
Regulates the LPS-Mediated Inflammatory Response In Vitro.
Previous reports have shown that LPS stimulation in mono-
cytescanresultinSer9phosphorylationofGSK3𝗽inaPI3K/
Akt-dependentpathway[27]andthatthispathwaydownreg-
ulates TLRs-dependent inflammatory responses. To investi-
gate the cellular mechanisms underlying our in vivo find-
ings, we analyzed whether CO-dependent activation of the
PI3K/AktpathwaymayregulateTLR4-dependentinflamma-
tory responses through GSK3𝗽 inhibition in vitro.L P S - s t i m -
ulated macrophages were first pretreated with the PI3K
inhibitor (LY294002) and then treated with a CO releasing
molecule(CORM2). Westernblot analysisshowedthattreat-
ment with CORM2 dramatically increased LPS-induced
phosphorylation of Akt, GSK3𝗽,a n di t sd o w n s t r e a mt a r g e t ,
the cAMP response element-binding protein (CREB). How-
ever, pretreatment with PI3K inhibitor (LY294002) inhibited
phosphorylation of GSK3𝗽, Akt, and CREB in LPS-stim-
ulated macrophages treated with CORM2 (Figure 4(a)).
In addition, GSK3𝗽 inactivation by CORM2 significantly
reduced TNF-𝗼 and increased IL-10 gene expression in res-
ponse to LPS (Figure 4(b)). The modulatory effects of
CORM2 on TNF-𝗼 and IL-10 expression were inhibited by
LY294002. These results demonstrate that CO-induced
GSK3𝗽 inactivation is mediated by the PI3K/Akt signaling
pathway and consequently modulates the TLR4-driven
inflammatory response.
3.5. Negative Regulation of GSK3 Activity by CO Affects the
AssociationsofNF-𝜅Bp65andCREBwithCBPTha tRegula tes
the Production of IL-10. We next sought to validate the cel-
lular mechanism by which CORM2-induced phosphoryla-
tion of GSK3𝗽 leads to the upregulation of the anti-inflam-
matory cytokine IL-10. Previous studies have identified
CREB,atargetofGSK3𝗽,asanimportanttranscriptionfactor
regulating IL-10 production in monocytes [28]. GSK3𝗽 can
negatively regulate the activation and DNA-binding activity
of CREB [28]. GSK3𝗽 increases the binding of NF-𝜅Bp 6 5t o
thecoactivatorCREB-bindingprotein(CBP),leadingtopro-
inflammatory gene activation, which competes against the
bindingofCREBtoCBP,thelatterregulatingIL-10expression
[27].
We sought to determine whether GSK3𝗽 inactivation
by CORM2 influenced the ability of CREB and NF-𝜅Bp 6 5
to associate with CBP. As shown in Figures 4(a) and 4(b),6 Oxidative Medicine and Cellular Longevity
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Figure 2: Inhibition of GSK3𝗽 by CO inhalation ameliorates liver I/R injury. Mice were sham-operated or subjected to 90minutes hepatic
warm ischemia followed by 1hour reperfusion. Recipients were treated with air or CO gas (250ppm) inhalation. (a) Liver samples, harvested
1hour later, were subjected to Western blot analysis of phospho (p)-GS (GS 641), p-GSK3𝗽 (S9), p-JNK, and p-p38. 𝗽-Actin was used as
an internal control.
∗𝑃 < 0.05,
∗∗∗𝑃 < 0.001. (b) Immunohistochemical staining of GSK3 inhibition. Mice were sacrificed, liver tissues
were harvested, and the tissue slices were processed for formalin-fixed paraffin embedding. Hematoxylin counterstaining after 3-amino-9-
ethylcarbazole-based immunohistochemical staining was used to detect GS 641 ((A)–(C), red/brown) and phosphorylation of GSK3𝗽 S9
((D)–(F), red/brown). ((c) and (d)) Quantitative RT-PCR-assisted detection of TNF-𝗼, IL-6, CXCL10, and IL-10gene expression at 1hour or
6hours in liver tissue. Data were normalized to 18S gene expression. Data shown represent the mean ± S.D. (𝑁 = 4-5/group),
∗𝑃 < 0.05.Oxidative Medicine and Cellular Longevity 7
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Figure 3: PI3K blockade restores liver I/R injury in mice pretreated with CO inhalation. Mice were treated with CO gas (CO), LY294002
(LY), or both or vehicle at 30minutes prior to the liver ischemia insult, as described in Materials and Methods. Liver samples were harvested
at 6hours after-reperfusion. (a) Proteins were analyzed by Western blotting with Abs against phosphorylated or total GSK3𝗽 and 𝗽-actin.
Sixty minutes ischemia time was used to show the effect of PI3K inhibition in liver I/R injury.
∗𝑃 < 0.05,
∗∗𝑃 < 0.01. (b) Average sALT
levelsindifferentexperimentalgroupsweremeasured.sALTlevelsweremeasuredat6hoursofreperfusion.(c)Representativeliverhistology
(H&E staining) is shown. To establish the functional relationship between PI3K and GSK3𝗽, CO inhalation was administered 12hr and LY
30minutespriortotheischemicinsultand6hrafterreperfusion.(d)Liverneutrophilaccumulation,assessedbyMPOactivity.Datarepresent
mean ± S.D. (𝑁 = 4–6samples/group).
∗∗𝑃 < 0.01,
∗∗∗𝑃 < 0.001.
LPS-stimulatedRAW264.7cellshadincreasedassociationof
p65withCBPrelativetounstimulatedcontrolcells.However,
LPS-stimulated cells that were pretreated with CORM2
showedaconsiderabledecreaseintheassociationofp65with
CBP (Figure 4(c)), whereas the binding of CREB to CBP was
potently augmented (Figure 4(d)), consistent with GSK3𝗽
inhibition.
4. Discussion
In the current study, we identify the GSK3𝗽 pathway as a
novel therapeutic target of the anti-inflammatory effects of
CO in a hepatic I/R injury model. The GSK3𝗽 pathway has
previously been identified as an important target of inflam-
matory regulation. GSK3𝗽 is a proline-directed Ser/Thr8 Oxidative Medicine and Cellular Longevity
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Figure 4: CO-induced PI3K/Akt-dependent GSK3 inactivation regulates TLR4 responses and affects the ability of CREB and NF-𝜅B-p65
to associate with CBP. RAW264.7 cells were stimulated with 100ng/mL of LPS for 1 hour in the absence or presence of CORM2 and the
PI3K inhibitor (LY294002). (a) Total cell lysates were analyzed for phosphorylated GS, GSK3𝗽, Akt, and CREB as well as total GS, GSK3𝗽,
Akt, CREB, and 𝗽-actin protein levels by Western immunoblot analysis. (b) The mRNA expression of TNF-𝗼 and IL-10 was determined by
semiquantitative RT-PCR. GAPDH was used as an internal control. ((c) and (d)) RAW264.7 cells were stimulated with 0.1𝜇g/mL of LPS for
1hour in the absence or presence of CORM2 (50𝜇M) and nuclear extracts were obtained. Interaction of CBP with NF-𝜅Bp 6 5a n dC R E Bw a s
assessed by immunoprecipitation of CBP followed by immunoblotting for NF-𝜅B or CREB. Total CBP served as the input standard.
kinase that phosphorylates a number of substrates including
glycogen synthase (GS) as well as constituents of numerous
intracellular signaling pathways including SMAD3, 𝗽-cate-
nin, NOTCH2, CREB, and others [29–31]. Recent studies
show that downregulation of GSK3𝗽 can negatively regulate
the inflammatory response and protect mice from endotoxin
shock [26]. In this model, GSK3𝗽 inhibition was asso-
ciated with increased cAMP-response element binding
(CREB) protein DNA binding activity, resulting in the in-
creased production of the anti-inflammatory cytokine IL-10
and the decreased NF-𝜅B-dependent production of pro-
inflammatory genes [26]. Recent studies have shown that
inhibition of GSK3𝗽 ameliorates liver I/R injury through an
IL-10 mediated immune regulatory mechanism [12]. During
myocardial infarction, GSK3 inhibition with pharmacolog-
ical inhibitors has been shown to exert a cardioprotective
effect, potentially related to inhibition of mitochondrial per-
meability transition pore opening [10].
Carbon monoxide (CO), which can be applied by inhala-
tion or by pharmacological delivery with CORMs, continues
toshowpromiseasananti-inflammatorytherapeuticsinsev-
eralmodelsoforganI/Rinjury.Forexample,inhaledCOcon-
ferred tissue protection in rodents subjected to lung I/R
injury, as evidenced by reduced markers of apoptosis, which
dependedonactivationoftheMKK3/p38MAPKpathway[8,
9]. Additionalmechanisms for CO-mediated protection dur-
ing lung I/R include the derepression of the fibrinolytic axis
and downregulation of the proinflammatory factor Egr-1Oxidative Medicine and Cellular Longevity 9
[32]. Furthermore, several studies demonstrated that pre-
treatment with CO donor compounds can ameliorate lung
transplant-associated I/R injury with increased hepatic
HSP70 expression [33] and can cause suppression of inflam-
matory responses via downregulation of the MEK/ERK1/2
signaling pathway [7].
In rodent models, CO has been shown to protect against
acute liver injurycaused by TNF𝗼 challenge [6]a n dca nc o n -
feranti-inflammatoryprotectioninhepaticI/Rinjurymodels
[7, 17, 34]. CO preserved hepatic function ex vivo in an iso-
lated perfused liver model subjected to cold ischemia injury,
in part by upregulating the p38 MAPK pathway [34]. CO
has been shown to protect against I/R injury during ortho-
tropic rat liver transplantation by downregulating pro-
inflammatory mediators, including TNF𝗼 and iNOS expres-
sion [17]. Furthermore, the protection afforded by CO in this
model was also associated with the modulation of STAT1/
STAT3 and inhibition of the MEK/ERK1/2 signaling pathway
[7].
ROS have been shown to be involved in the counter-reg-
ulation of inflammation in response to LPS treatment
throughmodulationofmacrophageproductionofIL-10[23].
Additionally, CO can act via inhibition of cytochrome c oxi-
daseleadingtothegenerationoflowlevelsofreactiveoxygen
species (ROS) that mediate adaptive signaling pathways [35].
Our data demonstrate that CO inactivates GSK3𝗽 through a
mechanism that involves increased ROS-induced Akt phos-
phorylation. These results provide evidence that the protec-
tive effects of CO are mediated through redox mechanisms
t h a tc a nl e a dt ot h ea c t i v a t i o no fa d a p t i v ep a t h w a y s .
The phosphatidylinositol-3-kinase (PI3K)/Akt pathway
represents another multifunctional signaling pathway that
promotes cell survival under adverse conditions. Previous
s t u d i e sh a v ei m p l i c a t e dt h eP I 3K / A k tp a t h w a yi nt h ec y t o -
protective effects of CO. For example, during anoxia/reox-
ygenation of pulmonary endothelial cells, CO treatment pro-
tected against apoptosis by upregulating the p38 MAPK
and PI3K/Akt-dependent STAT3 pathway. The protection
afforded by CO in a cardiac I/R injury model in vivo has also
been shown to be dependent on the activation of the p38
MAPK and PI3K/Akt pathways.
The PI3K/Akt pathway has been identified as an impor-
tant regulator of GSK3 signaling. PI3K/Akt-dependent inhi-
bition of GSK3𝗽 activity in monocytes regulates TLR-de-
pendent activation of inflammatory responses [13, 14]. Acti-
vation of the PI3K/Akt pathway resulting in Ser9 dependent
phosphorylation of GSK3𝗽 signaling pathway and inhibition
of NF-𝜅B nuclear translocation were shown to contribute to
cardioprotection during myocardial I/R injury [11]. Consis-
tent with these observations, our in vivo data demonstrate
that CO activates PI3K/Akt signaling to promote GSK3𝗽
inhibition through phosphorylation at Ser9 during hepatic
I/Rinjury.Furthermore,wehaveshownthatactivationofthis
pathwaybyCOtherapyisacrucialmediatoroftheprotection
afforded by CO against hepatic injury and inflammation dur-
ing I/R injury in mice.
GSK3𝗽 can differentially regulate TLR4-dependent sig-
naling leading to modulation of anti-/proinflammatorycyto-
kine balance. LPS stimulation in monocytes has been shown
to result in Ser9 phosphorylation of GSK3𝗽 in a PI3K/Akt-
dependent pathway [26], which downregulates TLRs-
dependent inflammatory responses. Hepatic warm ischemia
and reperfusion (I/R) injury and inflammation are largely
TLR4-dependent, whereas TLR4 appears to have marginal
role in the early liver inflammatory response [36]. GSK3𝗽
inhibition was associated with hepatoprotection through the
augmentation of the expression of the anti-inflammatory
cytokine IL-10. Consistently, our results demonstrate that
GSK3𝗽 inactivation by CO results in IL-10 upregulation in
macrophages through a mechanism involving the augmenta-
tion of the binding of CREB to the nuclear co-activator CBP,
leading and the suppression of the binding of NF-𝜅Bp 6 5t o
the nuclear coactivator CBP.
In summary, our results establish a signaling pathway by
which CO can confer anti-inflammatory protection in the
liver: CO activates PI3K/Akt which results in inhibition of
GSK3𝗽 through Ser9 phosphorylation, leading to the down-
regulation of TLR4-dependent proinflammatory cytokines,
and the upregulation of IL-10. The latter effect is mediated
through activation of CREB and disruption of the p65/CBP
interaction. Our results further validate the use of CO as a
pharmacological cytoprotective agent against hepatic I/R
injuryandidentifyGSK3𝗽asamajortherapeutictargetofCO
action in the liver.
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